What the Biggest ASCO Cancer Research Updates Could Mean for Patients - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

What the Biggest ASCO Cancer Research Updates Could Mean for Patients

Each year, the American Society of Clinical Oncology Annual Meeting brings together cancer specialists from around the world to share the research most likely to shape the next chapter of cancer care. This year’s major updates point to several important themes: more precise treatment, smarter use of surgery and chemotherapy, new approaches for difficult-to-treat cancers and a growing recognition that supportive care, including exercise, can be part of cancer treatment planning.

  • By

  • June 8, 2026

  • 10 min

Share

Clinical Scorecard: What the Biggest ASCO Cancer Research Updates Could Mean for Patients

At a Glance

CategoryDetail
ConditionSpecify cancers if mentioned in the source.
Key MechanismsEnsure terms are directly sourced.
Target PopulationAlign with specific patient groups mentioned.
Care SettingConfirm if mentioned in the source.

Key Highlights

  • V
  • e
  • r
  • i
  • f
  • y
  • e
  • a
  • c
  • h
  • h
  • i
  • g
  • h
  • l
  • i
  • g
  • h
  • t
  • a
  • g
  • a
  • i
  • n
  • s
  • t
  • t
  • h
  • e
  • s
  • o
  • u
  • r
  • c
  • e
  • f
  • o
  • r
  • a
  • c
  • c
  • u
  • r
  • a
  • c
  • y
  • .

Guideline-Based Recommendations

Diagnosis

  • E
  • n
  • s
  • u
  • r
  • e
  • s
  • o
  • u
  • r
  • c
  • e
  • d
  • d
  • i
  • r
  • e
  • c
  • t
  • l
  • y
  • f
  • r
  • o
  • m
  • t
  • h
  • e
  • c
  • o
  • n
  • t
  • e
  • x
  • t
  • .

Management

  • R
  • e
  • m
  • o
  • v
  • e
  • u
  • n
  • s
  • u
  • p
  • p
  • o
  • r
  • t
  • e
  • d
  • r
  • e
  • c
  • o
  • m
  • m
  • e
  • n
  • d
  • a
  • t
  • i
  • o
  • n
  • s
  • .

Monitoring & Follow-up

  • C
  • o
  • n
  • f
  • i
  • r
  • m
  • i
  • f
  • s
  • t
  • a
  • t
  • e
  • d
  • i
  • n
  • t
  • h
  • e
  • s
  • o
  • u
  • r
  • c
  • e
  • .

Risks

  • E
  • n
  • s
  • u
  • r
  • e
  • t
  • h
  • i
  • s
  • i
  • s
  • a
  • d
  • i
  • r
  • e
  • c
  • t
  • q
  • u
  • o
  • t
  • e
  • o
  • r
  • s
  • o
  • u
  • r
  • c
  • e
  • d
  • s
  • t
  • a
  • t
  • e
  • m
  • e
  • n
  • t
  • .

Patient & Prescribing Data

Remove unsupported claims about investigational drugs.

Clinical Best Practices

  • E
  • n
  • s
  • u
  • r
  • e
  • p
  • r
  • a
  • c
  • t
  • i
  • c
  • e
  • s
  • a
  • r
  • e
  • d
  • i
  • r
  • e
  • c
  • t
  • l
  • y
  • q
  • u
  • o
  • t
  • e
  • d
  • o
  • r
  • s
  • o
  • u
  • r
  • c
  • e
  • d
  • .

Related Resources & Content

    Original Source(s)

    What the Biggest ASCO Cancer Research Updates Could Mean for Patients

    • by

    • June 8, 2026

    Related Content

    Personalized Breast Cancer Screening: Moving Beyond Age-Based Algorithms

    Breast cancer screening has traditionally been organized around two principal variables: when mammography should begin and how frequently it should be performed.

    • by

    • October 16, 2026

    • 7 min
    Molecular Diagnostics Go Mobile

    A smartphone-linked fluorimeter detects infectious disease and cancer biomarkers in 10-minute assays

    • August 31, 2026

    • 3 min
    2026 ASCO Breast Cancer Highlights: SENOMAC

    Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

    • October 15, 2026

    • 1 min